Volpara Health, a maker of artificial intelligence breast-cancer-screening products, has acquired CRA Health, a breast cancer risk-assessment startup out of Massachusetts General Hospital.
Under the terms of the deal, Volpara will purchase all outstanding equity of CRA for $18 million, in addition to $4 million upon meeting strategic performance goals over the next year-and-a-half.
CRA’s risk...
